Statistics

Journal Profile  :
ISSN No. :2764-622X
Journal Title :Journal of Bioengineering Technologies and Health
Journal URL :www.jbth.com.br
Publisher Name :Leone Peter Andrade
Country :Brazil
Language :English
Discipline :Multidiciplinary
Organization Name :SENAI CIMATEC
Frequency :Quarterly
Start Year :2018
Journal Description :The Journal of Bioengineering, Technologies and Health (JBTH) is an official publication of SENAI CIMATEC (Serviço Nacional de Aprendizagem Industrial - Centro Integrado de Manufatura e Tecnologia). It is published quarterly (March - June - September - December). JBTH is a peer-reviewed open access and multidisciplinary Journal with an aim to develop a platform for innovative researchers in the area of Bioengineering, Technologies and Health. JBTH is published on March, June, September, December, in English, by SENAI-CIMATEC in the press and electronic editions by the home page www.jbth.com.br. JBTH has a DOI: 10.34178 for all its articles and editions. In 2022, it was classified for the first time by Qualis as category B2 (ISSN: 2595-2137 / e-ISSN 2674-8568). Today JBTH has a new ISSN (ISSN: 2764-5886 / e-ISSN: 2764-622X), but in Health fields, it focuses on Bioengineering and Technology applied to Health. However, due to the increase in the number of articles denied by the JBTH that included in their scope several areas related to engineering and bioengineering, chemistry, artificial intelligence, and substantial other technologies but not directly linked to the health area, many highly relevant papers had to be out of the Journal. As one of the crucial responsibilities of the Editorial Board is to evaluate the scope of the papers, they have stressed how significant the other areas of SENAI CIMATEC advances are to scientific discovery and development and decided to extend the scope of JBTH to include papers that provide the engineerings, bioengineering, technologies, chemistry, and related areas, but not linked just for health. In this sense, we have already received many strong submissions in many fields we expected. Now, the Journal reflects on the evolution we have seen. We will ensure it remains relevant and interesting to our readers and researchers. However, in order to not lose the indexes DOI and Crossref, the acronym and the website remained the same, changing only the name, the editorial board, and the scope of the Journal. JBTH intends to publish articles focusing on the subjects listed below: • Research, Development, and Innovation (R&D&I); • Need for highly improved connectivity (urban areas); • Availability of Data in real time; • Instant availability of services or customized service aggregates; • Sensors can be transformed into algorithms and service platforms that could be connected to the real world to the virtual world (Cyber-physical Systems); • Data that can become a commodity; • Treatments move based on “empirical data” to “customized” = Precision Medicine; • Management of millions of “cases” through “robots” and “algorithms” (Population Health Management); • Health 4.0; • Devices: Applied to Health, Healthcare, Chemical, Bioengineering and Biotechnology; • Bioengineering subjects such as biomechanics, clinical engineering, genetic engineering; or engineering methods to achieve biosynthesis of animal or plant products; • All news about technologies around the world; • Industry 4.0. Researches The Journal will provide an opportunity to researchers and scientists to explore the advanced and latest research developments, advancement discoveries and applications in in the field of bioengineering (electrical, chemical, mechanical, and other engineering disciplines related to medicine and biology, such as biomechanics, clinical engineering, genetic engineering; or the use of engineering methods to achieve biosynthesis of animal or plant products); technologies (all disciplines related to technology), Health (medicine, biology, chemistry, environmental areas and discilines related, as well as nanotechnologies, biochips, medical electronics, medical devices, new therapeutic strategies including stem cell therapy, gene therapy, new molecular biology discoveries and any scientific reliable information on advanced and very latest research topics). JBTH is strived to publish and get a positive impact factor through the following strategies: Accept submissions from everywhere in the world scientific community, track published in three weeks with a fast peer-review process, and no charge for publishing pages and figures. JBTH will bring three new approaches for regular publications and get a positive impact factor through the following strategies: • The editorial board of the journal consists of the prominent names of Bioengineering, Technologies and Health in all regions of the world, which will be relevant for the reviewing process. • Each edition will bring a feature article with commentaries by prominent researchers, and current trends and best practices are regularly covered in review articles and practice guidelines. • Every edition will bring innovative manuscripts of technological production in Brazil and worldwide through the new section created (“Health Innovation Initiatives”). • Quick peer-review process (no more than three weeks of the reviewers) and fast revision and publication (one week). If an author sends an article and it is accepted to the Journal after the three weeks of the reviewer’s process, and the author send back in 15 days, the article will be published in the next issue. JBTH includes the following categories of communications: • Original basic or clinical investigation; • Case presentation; • Brief reports or short communications; • State-of-the-art presentations; • Letters to the editor or editorials; • Editor's corner; • Innovative medical products; • Review article; • Health innovation initiatives.
Licence Type :CC BY-NC-SA
Issues published by the journal ::

WorldCat Database Search Engine